The South Africa Neurology Clinical Trials market is projected to grow from $34 Mn in 2022 to $57.2 Mn by 2030, registering a CAGR of 6.73% during the forecast period of 2022 - 2030. The market will be driven by the availability of a diverse population, a large number of well-trained healthcare professionals and modern medical healthcare facilities. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Eli Lilly and Company & Biovac.
South Africa Neurology Clinical Trials Market Executive Summary
The South Africa Neurology Clinical Trials market is projected to grow from $34 Mn in 2022 to $57.2 Mn by 2030, registering a CAGR of 6.73% during the forecast period of 2022 - 2030. South Africa ranks second, accounting for 19.9% of studies, followed by Uganda and Kenya, for clinical trials undertaken in Africa. Neurological disorders caused by neuro infections are very common in Sub-Saharan Africa (SSA), posing a significant impairment and economic burden on individuals and society. Epilepsy, dementia, motor neuron diseases, headache problems, sleep disorders, and peripheral neuropathy were among them. According to the most recent WHO statistics, Alzheimer's and Dementia fatalities in South Africa reached 4,676 in 2020, accounting for 1.03% of all fatalities.
Clinical trials are an important component of medical research since they are used to assess the safety and effectiveness of novel medications, medical equipment, or therapies. Clinical trials are carried out to ensure that novel therapy or medicines are safe, effective, and suitable for use in the treatment of patients. Neurology clinical trials especially concentrate on therapies for neurological illnesses, including Alzheimer's disease, multiple sclerosis, Parkinson's disease, stroke and others. South Africa has a well-developed healthcare system and has been active in clinical studies for many years. The country's population is diversified, making it an appealing site for clinical studies that need a broad patient group. Moreover, South Africa is a popular location for international clinical trials due to its high number of well-trained healthcare personnel and advanced medical facilities.
The South African Health Products Regulatory Authority (SAHPRA) is the regulatory body in charge of pharmaceuticals, clinical trials, medical devices, and radiation safety in South Africa. As stated in the Medicines and Related Substances Act (MRSA), Medicines and Related Substances Act, General Regulations (GRMRSA), and ZAF-10, SAHPRA is responsible for clinical trial monitoring, approval, and examinations in South Africa. In line with the rules of the GRMRSA, the agency gives authorisation for clinical studies to be undertaken in South Africa.
Market Growth Drivers
Many variables influence the South African neurology clinical trials market. The prevalence of neurological illnesses such as Alzheimer's disease, multiple sclerosis, and Parkinson's disease is increasing in South Africa. As a consequence, there is a growing need for innovative and effective therapies for these disorders, resulting in an increase in demand for neurology clinical trials in the nation. South Africa's healthcare system is well-developed, with sophisticated medical facilities, a huge pool of well-trained healthcare personnel, and a diversified patient population. These qualities make South Africa an appealing destination for clinical trials, especially those requiring a varied patient group. Moreover, the South African government has created regulatory authorities, such as The South African Health Products Regulatory Authority (SAHPRA), to oversee that clinical trials undertaken in the nation follow stringent ethical and safety criteria. This has produced a favourable climate for clinical trial sponsors, aiding in the expansion of the neurology clinical trials market.
There are various factors influencing the neurology clinical trials industry in South Africa. To begin, the nation continues to confront enormous socioeconomic obstacles, such as poverty, inequality, and a high burden of infectious illnesses such as HIV/AIDS and TB. These limitations may make recruiting people for clinical trials challenging and may restrict the country's market potential for neurology clinical studies. Moreover, there are practical obstacles connected with conducting clinical trials in South Africa, such as infrastructure, transportation, and communication concerns. These obstacles may raise the expense and difficulty of conducting clinical trials in the nation, discouraging some sponsors from entering the market.
July 2021, Pfizer and BioNTech Establish a Partnership with Biovac to Produce and Distribute COVID-19 Vaccine Doses in Africa
December 2022, Lilly and EVA Pharma Establish Partnership to Provide Long-Term Access to Low-Cost Insulin in Africa
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
22.214.171.124 Product Applications and Services
126.96.36.199 Recent Developments
188.8.131.52 Partnerships Ecosystem
184.108.40.206 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
6. Methodology and Scope
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses